How Stella Vnook is 'infusing innovation' into cell therapies with Likarda's technology 14-Feb-2024 By Isabel Cameron Stella Vnook, a seasoned veteran in the pharmaceutical industry with extensive experience in senior leadership roles at Catalent, Merck, and Diverse Biotech, has been a prominent figure in the field, particularly in oncology, for over 25 years.
'Untapped potential for cord blood in disease treatment’ 04-Jul-2022 By Jane Byrne Cell and gene therapy (CGT) researchers have been demonstrating the value of cord blood units as a source material.
